Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-29
1996-05-28
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514866, 514922, A61K 3140
Patent
active
055212085
ABSTRACT:
Disclosed are novel compositions comprising mixtures useful to treat the metabolically impaired and to improve patient compliance. Included are non-racemic mixtures of certain chiral spirofluorenehydantoins. Methods of use to treat glucose toxicity and complications arising from diabetes mellitus are also disclosed.
REFERENCES:
patent: 4130714 (1978-12-01), Sarges
patent: 4864028 (1989-09-01), York, Jr.
patent: 5151544 (1992-09-01), DuPriest et al.
Ariens, "Nonchiral, Homochiral and Composite Chiral Drugs" Trends in Pharmacologica Sciences 14:68-G35172 5 (Feb. 1993).
DuPriest, et al., "Spiro[fluoreneisothiazolidin]one Dioxides: New Aldose Reductase and L-Hexonate Dehydrogenase Inhibitors" J. Med. Chem 34:3229-3234 (1991).
Cholerton et al., "The role of individual human cytochromes P450 in drug metabolism and clinical response," TiPS, 13:434-439 (1992).
Drayer, "Pharmacodynamic and pharmacokinetic differences between drug enantiomers in humans: An overview," Clin. Pharmacol. Ther., 40:125-133 (1986).
Kiss et al., "Oxidation of Aldose Reductase Inhibitors AL0-4114 and AL0-3152 Catalyzed by Liver Microsomes," Drug Metabolism and Disposition, 20:948-953 (1992).
Park et al., "Comparison of the Pharmacokinetics and Pharmacodynamics of the Aldose Reductase Inhibitors, AL03152 (RS), AL03801 (R), and AL03803 (S)," Pharm. Res., 10:593-597 (1993).
Sarges et al., "Synthesis of Optically Active Spirohydantoins by Asymmetric Induction. Hydantoin Formaton from Amino Nitriles and Chlorosulfonyl Isocyanate," J. Org. Chem., 47:4081-4085 (1982).
DeCamp, "The FDA Perspective on the Development of Stereoisomers," Chirality 1:2-6(1989).
Tobert et al., "Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio," Clin. Pharmacol. Ther., 29(3):344-350 (1981).
Alcon Laboratories Inc.
Arno James A.
Cintins Marianne M.
Copeland Barry L.
MacMillan Keith
LandOfFree
Compositions and methods for the treatment of the metabolically does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for the treatment of the metabolically , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of the metabolically will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-787242